Pricing Log in Create free account

LivaNova PLC (LIVN) vs 10x Genomics (TXG)

LivaNova PLC and 10x Genomics are both Medical Devices companies. 10x Genomics is the larger, with a market value of $7.6B against $5.0B — 1.5× the size. 10x Genomics has negative trailing earnings, so its P/E is not meaningful; LivaNova PLC trades at 25.6×. LivaNova PLC grew revenue faster over the last twelve months: 11.7% against −4.28%. LivaNova PLC has the higher net margin (13.0% vs −12.2%) and the higher return on invested capital (9.14% vs −20.2%). Across the 19 metrics below, LivaNova PLC leads on 13 and 10x Genomics on 6.

Valuation

Metric LIVN TXG Medical Devices median
P/E 25.58 n/m 25.58
P/S 3.35 12.35 2.54
P/B 3.81 9.23 2.48
Price to free cash flow 37.98 63.28 28.81
EV/EBITDA 17.56 n/m 11.51
EV/Sales 3.18 11.51 2.72
Earnings yield 3.91% (1.01%) (12.82%)
Free cash flow yield 2.63% 1.58% (8.18%)

Profitability

Metric LIVN TXG Medical Devices median
Gross margin 67.84% 70.03% 57.76%
Operating margin 10.75% (14.33%) (15.07%)
Net margin 13.01% (12.18%) (14.45%)
Free cash flow margin 9.05% 19.68% (3.88%)
Return on equity 15.50% (9.40%) (10.35%)
Return on assets 7.44% (7.47%) (17.26%)
Return on invested capital 9.14% (20.20%) (5.27%)

Growth

Metric LIVN TXG Medical Devices median
Revenue growth (TTM) 11.71% (4.28%) 10.41%
EPS growth (last fiscal year) (483.62%) 76.97% 28.17%
Revenue growth, 5-year CAGR 8.24% 16.55% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LIVN TXG Medical Devices median
Debt to equity 0.22 0.00 0.04
Current ratio 1.74 5.69 2.74
Net debt to EBITDA (0.92) 30.49 0.54

Dividend

Metric LIVN TXG Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric LIVN TXG Medical Devices median
Market cap 5.02b 7.56b 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack